Belgium· BE-AMP-SAM266454-00
Certican 0.1 mg
A everolimus product containing everolimus, registered in Belgium by Novartis Pharma. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Everolimus is registered in 9 of 19 countries.
Countries holding a registration under ATC L04AH02 (everolimus), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 6 of them publish a price we can compare per daily dose
Everolimus · ATC L04AH02
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Switzerlandprice
Price per daily dose
What a daily dose of everolimus costs, country by country.
Normalised to the WHO defined daily dose (1.5 mg), the median price runs from $4.19 in United States to $20.09 in Switzerland — a ×4.8 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Everolimus · price per daily dose (1.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$20.09
- ES Spain$15.84
- US United States$4.19 (acquisition cost)
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Everolimus
- Manufacturer
- Novartis Pharma
- Country
- Belgium (BE)
- ATC code
- L04AH02
- ATC class
- Everolimus
- Defined daily dose
- 1.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
428 interactions on record for everolimus.
Graded by severity as the source publishes them — 165 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Everolimus · interactions on record
428 records
- 165 severe
- 255 moderate
- 8 minor
Most severe, free to view
- AprepitantA04AD12severe
- NeomycinA07AA01severe
- StreptomycinA07AA04severe
- Polymyxin BA07AA05severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Everolimus in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCERTICAN 0,1 mg COMPRIMIDOS DISPERSABLESNovartis Farmaceutica S.A.
- FinlandCerticanNovartis Finland Oy
- FranceCERTICAN 0,1 mg, comprimé dipersibleNOVARTIS PHARMA
- NorwayCerticanNovartis Norge (2)
- SwedenCertican 0,1 mg Dispergerbar tablettNovartis Sverige AB
- United StatesAfinitorNovartis Pharmaceuticals Corporation
- CzechiaAFINITORNovartis Europharm Limited, Dublin
- NetherlandsAfinitor 10 mg, tablettenNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Certican, Everolimus Ethypharm
- Bulgaria · Еверолимус Крка, Еверолимус Майлан
- Cyprus · Certican, Everolimus Pharmazac
- Czechia · Certican, Everolimus Accord
- Germany · Certican, Everofin
- Denmark · Certican, Everolimus Krka
- Estonia · Certican, Everolimus Krka
- Spain · Certican, Everolimus Accord
- Finland · Aderolio, Certican
- France · Certican, Everolimus Arrow
- United Kingdom (Northern Ireland) · Aderolio, Aderolio 250 Mcg Tablets
- Greece · Certican, Everolimus Faran
- Croatia · Certican, Everolimus Krka
- Hungary · Certican, Everolimus Accord
- Ireland · Certican, Everolimus Tad
- Iceland · Afinitor, Certican
- Italy · Certican, Everolimus Accord
- Liechtenstein · Afinitor, Votubia
- Lithuania · Certican, Everolimus Norameda
- Luxembourg · Certican, Everolimus Eg
- Latvia · Certican, Everolimus Norameda
- Malta · Certican, Everolimus Ascend
- Netherlands · Certican, Certican Dispers
- Norway · Afinitor, Certican
- Poland · Aderolio, Certican
- Portugal · Certican, Everolimus Ethypharm
- Romania · Certican, Everolimus Accord
- Sweden · Certican, Everolimus Avansor
- Slovenia · Certican, Everolimus Krka
- Slovakia · Certican, Everolimus Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a2113164-6afd-4e94-add4-4a385496f821 GET /v1/drugs/a2113164-6afd-4e94-add4-4a385496f821?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dispersible tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Certican 0.1 mg",
"name_fr": "Certican 0.1 mg",
"name_nl": "Certican 0.1 mg",
"amp_code": "SAM266454-00",
"strengths": [
"0.1000",
"0.1000",
"0.0100",
"71.5000",
"0.8900"
],
"pack_count": 4,
"substances": [
"Everolimus",
"Butylhydroxytoluene",
"Lactose",
"Lactose Monohydrate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Everolimus",
"authorisation_numbers": [
"BE266454"
]
}See everything about everolimus.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.